Back

Early detection of CTRCD by echocardiography among patients with breast cancer treated with anthracycline and trastuzumab stratified by HFA-ICOS risk classes

11 December 2024 (00:00 - 16:00)
Organised by: Logo
Congress Presentation Part of: Challenges in cardio oncology Imaging of Heart Failure EACVI Premium Access EuroEcho-Imaging 2024 European Association of Cardiovascular Imaging (EACVI)

About the speaker

Photo
Professor Hasan Al Farhan

Iraqi Board for Medical Specializations, Baghdad (Iraq)

3 More presentations in this session

Presentation thumbnail
Value of combined cardiopulmonary exercise testing with stress echocardiography in the management of late effects cardio-oncology patients.
Miss K. Donovan (London, GB)
Abstract Slides
Presentation thumbnail
Can flax "milk" prevent chemotherapy mediated cardiotoxicity in women with breast cancer?
Professor D. Jassal (Manitoba, CA)
Abstract Slides
Presentation thumbnail
Dapagliflozin improves ejection fraction, radial/longitudinal strain and reduces systemic H-FABP and pro-inflammatory cytokines in models of dororubicin/trastuzumab induced cardiotoxicity
Doctor N. Maurea (Naples, IT)
Abstract Slides

Access the full session

Session thumbnail
Challenges in cardio oncology

The Event

Event poster

EuroEcho-Imaging 2024

11 December - 13 December 2024
You may be interested in
thumbnail
Congress Presentation
Heart failure
thumbnail
Congress Presentation
What is the best imaging method to assess myocardial viability? 
thumbnail
Congress Session
Recent advances in clinical practice guidelines: what the imager needs to know and apply - Part 2

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources